搜索临床试验以:Zanubrutinib 和利妥昔单抗
总计272371个结果
-
MEI Pharma, Inc.终止慢性淋巴细胞白血病 (CLL) | 小淋巴细胞淋巴瘤 (SLL) | 套细胞淋巴瘤 (MCL) | 弥漫性大 B 细胞淋巴瘤 (DLBCL) | 滤泡性淋巴瘤 (FL) | 边缘区B细胞淋巴瘤 | 高级别非霍奇金淋巴瘤美国, 瑞士
-
University of Auckland, New ZealandAuckland District Health Board未知
-
Wake Forest University Health Sciences完全的
-
Huazhong University of Science and Technology招聘中
-
Dana-Farber Cancer Institute邀请报名
-
H. Lee Moffitt Cancer Center and Research InstituteBeiGene, Ltd.招聘中
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Splendor-NC招聘中
-
Million Marker Wellness, Inc.完全的
-
Biocad招聘中
-
University Health Network, Toronto尚未招聘
-
Dana-Farber Cancer InstituteGenentech, Inc.; Biogen完全的
-
Shanghai Changzheng HospitalRenJi Hospital; Huashan Hospital; Shanghai 6th People's Hospital; Huadong Hospital招聘中
-
Shanxi Province Cancer Hospital尚未招聘
-
International Extranodal Lymphoma Study Group (IELSG)招聘中
-
i-Lumen Scientific, Inc.招聘中
-
Ottawa Hospital Research InstituteBioMérieux; Centre Hospitalier Régional et Universitaire de Brest完全的
-
Virginia Commonwealth UniversityHenrico County Public Schools; Virginia Department of Aging and Rehabilitative Services; Chesterfield...完全的
-
Maria Sklodowska-Curie National Research Institute...Centre of Postgraduate Medical Education; European Union未知
-
George Washington UniversityPatient-Centered Outcomes Research Institute; University of Bristol; West Virginia University...尚未招聘
-
Fire Brigade Of Paris Emergency Medicine DeptBrigade de Sapeurs Pompiers de Paris; Physio-Control, Inc, A division of Medtronic完全的
-
Sarah CockayneUniversity of Nottingham; James Cook University, Queensland, Australia; Queensland Health; Humberside... 和其他合作者终止
-
Children's Oncology GroupNational Cancer Institute (NCI)主动,不招人EBV 相关的移植后淋巴增生性疾病 | 单形性移植后淋巴增生性疾病 | 多态性移植后淋巴增生性疾病 | 复发性单形性移植后淋巴增生性疾病 | 复发性多态性移植后淋巴增生性疾病 | 难治性单形性移植后淋巴增生性疾病 | 难治性多态性移植后淋巴增生性疾病美国